Structure-Based Optimizationof Tyrosine Kinase Inhibitor CLM3. Design, Synthesis,Functional Evaluation, and MolecularModeling Studies.

MLA

Sartini, Stefania, et al. “Structure-Based Optimizationof Tyrosine Kinase Inhibitor CLM3. Design, Synthesis,Functional Evaluation, and MolecularModeling Studies.” Journal of Medicinal Chemistry, vol. 57, no. 4, Feb. 2014, pp. 1225–35. EBSCOhost, https://doi.org/10.1021/jm401358b.

APA

Sartini, S., Coviello, V., Bruno, A., La Pietra, V., Marinelli, L., Simorini, F., Taliani, S., Salerno, S., Marini, A. M., Fioravanti, A., Orlandi, P., Antonelli, A., Da Settimo, F., Novellino, E., Bocci, G., & LaMotta, C. (2014). Structure-Based Optimizationof Tyrosine Kinase Inhibitor CLM3. Design, Synthesis,Functional Evaluation, and MolecularModeling Studies. Journal of Medicinal Chemistry, 57(4), 1225–1235. https://doi.org/10.1021/jm401358b

Chicago

Sartini, Stefania, Vito Coviello, Agostino Bruno, Valeria La Pietra, Luciana Marinelli, Francesca Simorini, Sabrina Taliani, et al. 2014. “Structure-Based Optimizationof Tyrosine Kinase Inhibitor CLM3. Design, Synthesis,Functional Evaluation, and MolecularModeling Studies.” Journal of Medicinal Chemistry 57 (4): 1225–35. doi:10.1021/jm401358b.